
Bilal Abid
Hematologist-oncologist and Medical Director of Blood and Marrow Transplantation & Cellular Therapy at Texas Tech University Health Sciences Center.
1
APPEARANCES
1
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
SEP 28
OCT 5
OCT 12
OCT 19
OCT 26
Sep 29, 2026
Understanding Blood Cancers: From Diagnosis to Treatment Pathways
9:21
9:30
9:50
9:06
Vin, can you tell us how do you treat blood cancers and how long does treatment usually last? What happens if it's left untreated?

Bilal AbidGUEST
What happens if we leave a blood cancer untreated depends entirely upon the type of the underlying blood cancer.

Bilal AbidGUEST
If it's ALL or AML or acute leukemia, that can't be left untreated beyond a certain number of days because the rate of growth of leukemia cells is fast and it kills individuals at a rapid pace.

Bilal AbidGUEST
Unlike that, There's a good proportion of patients with CLL, chronic lymphocytic leukemia.
13:05
What are the chances? I know you mentioned that some are just like chronic illnesses now, but what are the chances of it recurring in adults or in children after treatment?
